MedPath

Novocol Pharmaceutical of Canada, Inc.

🇨🇦Canada
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

4

FDA:4

Drug Approvals

Lidocaine

Approval Date
Dec 15, 2011
FDA

Lignospan Standard

Approval Date
Nov 15, 2011
FDA

LIDOCAINE

Approval Date
Nov 7, 2011
FDA

Lidocaine Hydrochloride and Epinephrine Bitartrate

Approval Date
Nov 7, 2011
FDA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients

Phase 4
Completed
Conditions
Anesthesia, Local
Dental Anesthesia
Anesthesia, Reversal
Interventions
Other: Sham injection
First Posted Date
2011-11-18
Last Posted Date
2014-08-29
Lead Sponsor
Novocol Pharmaceutical of Canada, Inc.
Target Recruit Count
150
Registration Number
NCT01474382
Locations
🇺🇸

University of California, San Francisco, San Francisco, California, United States

🇺🇸

Indiana University School of Dentistry, Indianapolis, Indiana, United States

🇺🇸

Nationwide Children's Hospital, Columbus, Ohio, United States

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.